MAPT and Alzheimer disease: Attenuation of Tau hyperphosphorylation was also observed in the THY-Tau22 transgenic mouse model of AD-like tauopathy [16], where palm11-PrRP31 treatment improved short-term spatial memory in the Y-maze test [17].